LANSDOWNE PARTNERS (UK) LLP 13D and 13G filings for Summit Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-06-17 2:38 pm Sale | 2020-06-12 | 13D | Summit Therapeutics Inc. SMMT | LANSDOWNE PARTNERS (UK) LLP | 13,664,880 4.060% | -4,006,035 (-22.67%) | Filing |
| 2020-05-15 10:18 am Sale | 2020-05-08 | 13D | Summit Therapeutics Inc. SMMT | LANSDOWNE PARTNERS (UK) LLP | 17,670,915 5.260% | -3,472,585 (-16.42%) | Filing |
| 2020-03-26 2:59 pm Unchanged | 2020-03-23 | 13D | Summit Therapeutics Inc. SMMT | LANSDOWNE PARTNERS (UK) LLP | 21,143,500 6.300% | 0 (Unchanged) | Filing |